May 21, 2025 12:50 PM EDTUpdated 01:40 PM

FDA adcomm narrowly votes against UroGen’s bladder cancer drug, calls for RCTs

Zachary Brennan

Senior Editor

The FDA’s Oncologic Drugs Advisory Committee on Wednesday voted 5 to 4 against UroGen Pharma’s mitomycin as an option for low-grade intermediate-risk non-muscle invasive bladder …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

FDA adcomm narrowly votes against UroGen’s bladder cancer drug, calls for RCTs

Zachary Brennan

Senior Editor

Sign up to read this article for free.

FDA asks Covid vaccine makers to add more myocarditis data to labels

Big leases, bigger regrets: Biotech slump turns swanky offices from asset into liability

Updated: Eikon Therapeutics cuts staff for the second time in less than two years

FDA announces efforts to facilitate drug importation from Canada

Altos Labs buys anti-aging startup Dorian Therapeutics

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?

FDA ad­comm nar­row­ly votes against Uro­Gen’s blad­der can­cer drug, calls for RCTs

Zachary Brennan

Senior Editor

Sign up to read this article for free.

FDA asks Covid vac­cine mak­ers to add more my­ocardi­tis da­ta to la­bels

Big leas­es, big­ger re­grets: Biotech slump turns swanky of­fices from as­set in­to li­a­bil­i­ty

Up­dat­ed: Eikon Ther­a­peu­tics cuts staff for the sec­ond time in less than two years

FDA an­nounces ef­forts to fa­cil­i­tate drug im­por­ta­tion from Cana­da

Al­tos Labs buys an­ti-ag­ing start­up Do­ri­an Ther­a­peu­tics

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

FDA adcomm narrowly votes against UroGen’s bladder cancer drug, calls for RCTs

FDA asks Covid vaccine makers to add more myocarditis data to labels

Big leases, bigger regrets: Biotech slump turns swanky offices from asset into liability

Updated: Eikon Therapeutics cuts staff for the second time in less than two years

FDA announces efforts to facilitate drug importation from Canada

Altos Labs buys anti-aging startup Dorian Therapeutics

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?